Catalent Pharma Solutions, today announced the appointment of Kunal Jaiswal to the role of Vice President, Strategic Development Solutions, Clinical Supply Services.
Somerset, N.J. – October 20 2016 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the appointment of Kunal Jaiswal to the role of Vice President, Strategic Development Solutions, Clinical Supply Services. In his role, Mr. Jaiswal will lead the company’s ongoing efforts to anticipate and act upon industry trends and technologies that may impact study sponsors, clinical sites, and patients, and to inform the development and delivery of current and future clinical supply services.
Mr. Jaiswal brings over ten years of clinical supply chain operations experience. Most recently he was Director of Clinical Supply Packaging Operations at Pfizer with a prior engagement at Merck as Head of Supply Chain Strategy. Mr. Jaiswal is a recognized industry expert and former Chair of the ISPE’s (International Society for Pharmaceutical Engineering) Investigational Products Steering Committee. He holds a Bachelor’s degree in pharmacy from Purdue University and a Master’s in business administration from Western Michigan University.
“Kunal is an important addition to our leadership team that will accelerate our ongoing efforts to develop and deliver industry-leading clinical supply solutions to our customers,” stated Wetteny Joseph, President of Catalent Clinical Supply Services. “His extensive experience brings our team a wealth of knowledge and unique customer perspective that will enable the next generation of clinical trial innovation in our industry.”
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 9,200 people, including over 1,400 scientists, more than 30 facilities across five continents, and in fiscal 2016 generated $1.85 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com